Finance

Lists
Q3 2026 earnings • released • EPS beat +8.76% • Revenue beat +0.94%
See results
6446:TPE
PharmaEssentia Corp
NT$1,300.00
-2.62%
(-35.00) 1D
Nov 12, 9:10:30 AM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6446...
Open
NT$1,310.00
High
NT$1,320.00
Low
NT$1,290.00
Mkt. cap
549.16B
Avg. vol.
2.51M
Volume
562.40K
Dividend
0.10%
Quarterly dividend
NT$0.34
Ex-dividend date
Sep 26, 2022
P/E ratio
72.62
52-wk high
NT$1,645.00
52-wk low
NT$407.92
EPS
NT$17.90
No. of employees
131
Open
NT$1,310.00
High
NT$1,320.00
Low
NT$1,290.00
Mkt. cap
549.16B
Avg. vol.
2.51M
Volume
562.40K
Dividend
0.10%
Quarterly dividend
NT$0.34
Ex-dividend date
Sep 26, 2022
P/E ratio
72.62
52-wk high
NT$1,645.00
52-wk low
NT$407.92
EPS
NT$17.90
No. of employees
131
News stories
From web sources and news partners
About PharmaEssentia Corp
CEO-
Employees131
FoundedMay 9, 1990
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepharmaessentia.com
Last report
Nov 11, 2026
Fiscal period
Q3 2026
NT$7.08 / NT$6.51
+8.76%beat
Revenue / Est. (TWD)
7.76B / 7.69B
+0.94%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.89B
4.88B
5.12B
6.86B
Cost of goods sold
327.93M
543.68M
621.28M
395.45M
Cost of revenue
327.93M
543.68M
621.28M
395.45M
Research and development expenses
884.63M
1.01B
857.29M
1.07B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.52B
1.77B
1.56B
2.24B
Operating expense
2.40B
2.78B
2.41B
3.31B
Total operating expenses
2.73B
3.32B
3.03B
3.70B
Operating income
1.17B
1.56B
2.09B
3.15B
Other non operating income
238.00K
4.37M
1.32M
8.58M
EBT including unusual items
1.41B
2.01B
2.34B
3.20B
EBT excluding unusual items
1.41B
2.01B
2.34B
3.20B
Income tax expense
-59.18M
536.45M
185.95M
668.64M
Effective tax rate
-4.19%
26.65%
7.96%
20.90%
Other operating expenses
-
-
-
-
Net income
1.47B
1.48B
2.15B
2.53B
Net profit margin
37.83%
30.24%
41.97%
36.90%
Earnings per share
3.60
3.58
5.21
6.13
Interest and investment income
123.73M
142.46M
139.53M
148.04M
Interest expense
-5.55M
-5.76M
-4.71M
-5.95M
Net interest expenses
118.18M
136.70M
134.82M
142.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.20B
1.60B
2.14B
3.21B
Gain or loss from assets sale
-
1.50M
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps